Journal Menu
► ▼ Journal Menu-
- Antibodies Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Most Cited & Viewed
Most Cited & Viewed Papers
Citations | Article |
---|---|
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
by
Kristin Widyasari and Jinnam Kim
|
|
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by
Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
|
|
Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by
Guanjie Li, Hiroyuki Suzuki, Teizo Asano, Tomohiro Tanaka, Hiroyoshi Suzuki, Mika K. Kaneko and Yukinari Kato
|
|
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by
Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
|
|
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation
by
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry and Suprabhat Mukherjee
|
|
IgY Antibodies as Biotherapeutics in Biomedicine
by
Diana León-Núñez, María Fernanda Vizcaíno-López, Magdalena Escorcia, Dolores Correa, Elizabeth Pérez-Hernández and Fernando Gómez-Chávez
|
|
FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis
by
Margaret A. Lindorfer and Ronald P. Taylor
|
|
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model
by
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K. Kaneko and Yukinari Kato
|
Citations | Article |
---|---|
The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
by
Razwana Khanam, Omer S. Ashruf, Syed Hamza Bin Waqar, Zunairah Shah, Saba Batool, Rameesha Mehreen, Pranali Pachika, Zinath Roksana, Mohammad Ebad Ur Rehman and Faiz Anwer
|
|
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
by
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
|
|
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by
Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
|
|
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
by
Jun Fang, Shifa Lai, Haoyang Yu and Lan Ma
|
|
Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by
Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
|
|
IgA Nephropathy: Current Treatment and New Insights
by
Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
|
|
Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test
by
Tatjana Vilibic-Cavlek, Maja Bogdanic, Ema Borko, Zeljka Hruskar, Denis Zilic, Thomas Ferenc, Irena Tabain, Ljubo Barbic, Mateja Vujica Ferenc, Ivana Ferencak and Vladimir Stevanovic
|
|
Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
by
Meshal Alshamrani
|
|
Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
by
Weronika Grąźlewska and Lucyna Holec-Gąsior
|
Citations | Article |
---|---|
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis
by
Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
|
|
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
|
|
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
by
Karsten Beckmann, Carmen Reitinger, Xianglei Yan, Anna Carle, Eva Blümle, Nicole Jurkschat, Claudia Paulmann, Sandra Prassl, Linda V. Kazandjian, Karin Loré, Falk Nimmerjahn and Stephan Fischer
|
|
Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury
by
Shu-Hsien Lin, Kun-Ta Wu, Chih-Chi Wang, Kuang-Tzu Huang, Li-Wen Hsu, Hock-Liew Eng and King-Wah Chiu
|
|
Prediction of Antibody Viscosity from Dilute Solution Measurements
by
Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh and Jeremy D. Schmit
|
|
Antiphospholipid Antibodies Associated with Native Arteriovenous Fistula Complications in Hemodialysis Patients: A Comprehensive Review of the Literature
by
Maxime Taghavi, Abla Jabrane, Lucas Jacobs, Maria Do Carmo Filomena Mesquita, Anne Demulder and Joëlle Nortier
|
|
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
by
Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilliadd
Show full author list
remove
Hide full author list
|
Citations | Article |
---|---|
Monoclonal Antibodies in Cancer Therapy
by
David Zahavi and Louis Weiner
|
|
Antibody Structure and Function: The Basis for Engineering Therapeutics
by
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
|
|
Design and Production of Bispecific Antibodies
by
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
|
|
David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
by
Adam Bates and Christine A. Power
|
|
IgA: Structure, Function, and Developability
by
Patrícia de Sousa-Pereira and Jenny M. Woof
|
|
Developments and Challenges for mAb-Based Therapeutics
by
Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake
|
|
The Ligands for Human IgG and Their Effector Functions
by
Steven W. de Taeye, Theo Rispens and Gestur Vidarsson
|
|
Autoantibodies in SLE: Specificities, Isotypes and Receptors
by
Barbara Dema and Nicolas Charles
|
|
Structure, Function, and Therapeutic Use of IgM Antibodies
by
Bruce A. Keyt, Ramesh Baliga, Angus M. Sinclair, Stephen F. Carroll and Marvin S. Peterson
|
|
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by
Rena Liu, Robert J. Oldham, Emma Teal, Stephen A. Beers and Mark S. Cragg
|
Views | Article |
---|---|
IgG Avidity Test as a Tool for Discrimination between Recent and Distant Toxoplasma gondii Infection—Current Status of Studies
by
Lucyna Holec-Gąsior and Karolina Sołowińska
|
|
A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting
by
Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa
|
|
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by
Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
|
|
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond
by
Marino Paroli, Chiara Gioia and Daniele Accapezzato
|
|
Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
by
Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
|
|
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by
Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
|
|
Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines
by
Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, Alecsander P. da Silva, Leland O. Barrett, Scott McGoldrick, Yuvraj Lnu, Shannon E. Lynch, Jared M. Boisclair, Dakarai D. Barnard-Pratt and Steven Zanganeh
|
|
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
by
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
|
|
IgA Nephropathy: Current Treatment and New Insights
by
Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
|
Views | Article |
---|---|
Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
by
Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
|
|
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
by
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
|
|
IgA Nephropathy: Current Treatment and New Insights
by
Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
|
|
Recent Progress in Antibody Epitope Prediction
by
Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
|
|
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
by
Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilliadd
Show full author list
remove
Hide full author list
|
|
Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
by
Weronika Grąźlewska and Lucyna Holec-Gąsior
|
|
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by
Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
|
|
Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
by
Daniel Chiu, John Rhee and L. Nicolas Gonzalez Castro
|
Views | Article |
---|---|
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
by
Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilliadd
Show full author list
remove
Hide full author list
|
|
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
|
|
Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines
by
Ramakrishnan Natesan, Andrew B. Dykstra, Akash Banerjee and Neeraj J. Agrawal
|
|
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis
by
Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
|
|
Prediction of Antibody Viscosity from Dilute Solution Measurements
by
Kamal Bhandari, Yangjie Wei, Brendan R. Amer, Emma M. Pelegri-O’Day, Joon Huh and Jeremy D. Schmit
|
|
An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies
by
Yinghui Rong, I-Ling Chen, Lance Larrabee, Manali S. Sawant, Germaine Fuh and Patrick Koenig
|
|
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by
Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
|
|
A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy
by
Nataliya M. Ratnikova, Yulia Kravchenko, Anna Ivanova, Vladislav Zhuchkov, Elena Frolova and Stepan Chumakov
|
|
Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies
by
Sarah Julien, Inès Challier, Marine Malleter, Fabienne Jouen, Laurent Drouot and Olivier Boyer
|
|
Rapid Generation of Murine Bispecific Antibodies Using FAST-IgTM for Preclinical Screening of HER2/CD3 T-Cell Engagers
by
Hikaru Koga, Haruka Kuroi, Rena Hirano, Hiroyuki Hirayama, Yoshiaki Nabuchi and Taichi Kuramochi
|
Views | Article |
---|---|
Antibody Structure and Function: The Basis for Engineering Therapeutics
by
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
|
|
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
by
Philippe P. Monnier, Robin J. Vigouroux and Nardos G. Tassew
|
|
Monoclonal Antibodies in Cancer Therapy
by
David Zahavi and Louis Weiner
|
|
Antibody Glycosylation and Inflammation
by
Kai-Ting C. Shade and Robert M. Anthony
|
|
Antibody Aggregation: Insights from Sequence and Structure
by
Wei Li, Ponraj Prabakaran, Weizao Chen, Zhongyu Zhu, Yang Feng and Dimiter S. Dimitrov
|
|
Design and Production of Bispecific Antibodies
by
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
|
|
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
by
Gustav Rodrigo, Mats Gruvegård and James M. Van Alstine
|
|
Antibody Drug Conjugates as Cancer Therapeutics
by
Pamela A. Trail
|
|
IgG Antibody 3D Structures and Dynamics
by
Jacob White Jay, Brinkley Bray, Yaozhi Qi, Eseosaserea Igbinigie, Hao Wu, Jinping Li and Gang Ren
|
|
Developments and Challenges for mAb-Based Therapeutics
by
Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake
|
Downloads | Article |
---|---|
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
by
Stefania C. Carrara, David Fiebig, Jan P. Bogen, Julius Grzeschik, Björn Hock and Harald Kolmar
|
|
Clinical Pharmacology of Antibody-Drug Conjugates
by
Iftekhar Mahmood
|
|
Introduction to Antibody-Drug Conjugates
by
Mark C. Pettinato
|
|
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by
Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
|
|
A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting
by
Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa
|
|
Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer
by
Violet Y. Tu, Asma Ayari and Roddy S. O’Connor
|
|
The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
by
Rita Tavarozzi and Enrica Manzato
|
|
The Different Colors of mAbs in Solution
by
Alexandre Ambrogelly
|
|
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by
Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
|
Downloads | Article |
---|---|
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by
Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
|
|
A New Method to Characterize Conformation-Specific Antibody by a Combination of Agarose Native Gel Electrophoresis and Contact Blotting
by
Teruo Akuta, Toshiaki Maruyama, Chiaki Sakuma, Masataka Nakagawa, Yui Tomioka, Kevin Entzminger, Jonathan K. Fleming, Ryo Sato, Takashi Shibata, Yasunori Kurosawa, C. J. Okumura and Tsutomu Arakawa
|
|
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by
Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
|
|
IgA Nephropathy: Current Treatment and New Insights
by
Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
|
|
Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules
by
Janine Dilchert, Martin Hofmann, Felix Unverdorben, Roland Kontermann and Sebastian Bunk
|
|
Antibody-Based Approaches to Target Pancreatic Tumours
by
Marie Sorbara, Pierre Cordelier and Nicolas Bery
|
Downloads | Article |
---|---|
IgA Nephropathy: Current Treatment and New Insights
by
Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
|
|
Recent Progress in Antibody Epitope Prediction
by
Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
|
|
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by
Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
|
|
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
|
|
The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
by
Razwana Khanam, Omer S. Ashruf, Syed Hamza Bin Waqar, Zunairah Shah, Saba Batool, Rameesha Mehreen, Pranali Pachika, Zinath Roksana, Mohammad Ebad Ur Rehman and Faiz Anwer
|
|
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
by
Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
|
|
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
by
Monica L. Fernández-Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, Valentin J. Hoerschinger, Katharina B. Kroell, Jakob R. Riccabona, Anna S. Kamenik, Johannes R. Loeffler, James A. Ferguson, Hailee R. Perrett, Klaus R. Liedl, Julianna Han and Andrew B. Ward
|
|
Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by
Chi Hun Song, Minchan Jeong, Hyukmin In, Ji Hoe Kim, Chih-Wei Lin and Kyung Ho Han
|
|
Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
by
Robert Pejchal, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez and Eric M. Krauland
|
Downloads | Article |
---|---|
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
|
|
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by
Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
|
|
Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis
by
Dimitrina Miteva, Georgi V. Vasilev and Tsvetelina Velikova
|
|
Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation and Ultraviolet Photodissociation
by
Eleanor Watts, Aarti Bashyal, Sean D. Dunham, Christopher M. Crittenden and Jennifer S. Brodbelt
|
|
Rapid Generation of Murine Bispecific Antibodies Using FAST-IgTM for Preclinical Screening of HER2/CD3 T-Cell Engagers
by
Hikaru Koga, Haruka Kuroi, Rena Hirano, Hiroyuki Hirayama, Yoshiaki Nabuchi and Taichi Kuramochi
|
|
Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
by
Karsten Beckmann, Carmen Reitinger, Xianglei Yan, Anna Carle, Eva Blümle, Nicole Jurkschat, Claudia Paulmann, Sandra Prassl, Linda V. Kazandjian, Karin Loré, Falk Nimmerjahn and Stephan Fischer
|
|
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
by
Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, Emiliano Pavoni, Fabiana Fosca Ferrara, Manuela Cappelletti, Roberto Arriga, Silvia Maria Serrao, Valentina Peluzzi, Eugenia Principato, Mirco Compagnone, Eleonora Pinto, Laura Luberto, Daniela Stoppoloni, Armin Lahm, Rüdiger Groß, Alina Seidel, Lukas Wettstein, Jan Münch, Andrew Goodhead, Judicael Parisot, Raffaele De Francesco, Gennaro Ciliberto, Emanuele Marra, Luigi Aurisicchio and Giuseppe Roscilliadd
Show full author list
remove
Hide full author list
|
|
Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines
by
Ramakrishnan Natesan, Andrew B. Dykstra, Akash Banerjee and Neeraj J. Agrawal
|
|
A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy
by
Nataliya M. Ratnikova, Yulia Kravchenko, Anna Ivanova, Vladislav Zhuchkov, Elena Frolova and Stepan Chumakov
|
|
Navigating the Challenges of Gluten Enteropathy and Infertility: The Role of Celiac-Related Antibodies and Dietary Changes
by
Monika Peshevska-Sekulovska, Milena Gulinac, Radoslav Rangelov, Desislava Docheva, Tsvetelina Velikova and Metodija Sekulovski
|
Downloads | Article |
---|---|
Developments and Challenges for mAb-Based Therapeutics
by
Sumit Goswami, Wei Wang, Tsutomu Arakawa and Satoshi Ohtake
|
|
Design and Production of Bispecific Antibodies
by
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland and Michael J. Betenbaugh
|
|
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
by
Gustav Rodrigo, Mats Gruvegård and James M. Van Alstine
|
|
Antibody Drug Conjugates as Cancer Therapeutics
by
Pamela A. Trail
|
|
Antibody Structure and Function: The Basis for Engineering Therapeutics
by
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov and Gary L. Gilliland
|
|
Monoclonal Antibodies in Cancer Therapy
by
David Zahavi and Louis Weiner
|
|
Antibody Glycosylation and Inflammation
by
Kai-Ting C. Shade and Robert M. Anthony
|
|
David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
by
Adam Bates and Christine A. Power
|
|
A Review of Deep Learning Methods for Antibodies
by
Jordan Graves, Jacob Byerly, Eduardo Priego, Naren Makkapati, S. Vince Parish, Brenda Medellin and Monica Berrondo
|